Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications.
作者信息
Mamdani Muhammad, Rochon Paula, Laupacis Andreas, Anderson Geoffrey
机构信息
Institute for Clinical Evaluative Sciences, Toronto, ON.
出版信息
CMAJ. 2002 Nov 12;167(10):1125-6.
Abstract
摘要
相似文献
1
2
The cox-2 inhibitors.环氧化酶-2抑制剂
J Mass Dent Soc. 1999 Fall;48(3):43-4.
3
Treating pain with COX-2 inhibitors.使用COX-2抑制剂治疗疼痛。
Nurse Pract. 1999 Nov;24(11):95-6, 99-100, 102.
4
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.罗非昔布和塞来昔布用于骨关节炎或类风湿关节炎患者的成本效益。
Arthritis Rheum. 2003 Jun 15;49(3):283-92. doi: 10.1002/art.11121.
5
Pharmacoutilization and costs of osteoarthritis: changes induced by the introduction of a cyclooxygenase-2 inhibitor into clinical practice.
Rheumatology (Oxford). 2003 Jul;42(7):879-87. doi: 10.1093/rheumatology/keg242. Epub 2003 Mar 31.
6
Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada.加拿大魁北克省接受COX-2选择性抑制剂或非选择性非甾体抗炎药治疗的老年患者的治疗转换及相关费用
Rheumatology (Oxford). 2006 Jul;45(7):903-10. doi: 10.1093/rheumatology/kei269. Epub 2006 Feb 3.
7
Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.类风湿性关节炎和骨关节炎患者使用COX-2特异性抑制剂和非特异性非甾体抗炎药之间的药物转换模式。
Pharmacoepidemiol Drug Saf. 2004 May;13(5):277-87. doi: 10.1002/pds.909.
8
Differences between COX-2-specific inhibitors: clinical and economic implications.COX-2特异性抑制剂之间的差异：临床及经济意义
Am J Manag Care. 2002 Oct;8(15 Suppl):S428-30.
9
Selective COX-2 inhibition.选择性环氧化酶-2抑制
Bull Rheum Dis. 1999;48(2):1-4.
10
The pain game.疼痛游戏。
Nature. 2007 Jul 26;448(7152):400-1. doi: 10.1038/448400a.
引用本文的文献
1
Decoction of Heat-Clearing, Detoxifying and Blood Stasis Removing Relieves Acute Soft Tissue Injury via Modulating MiR-26b-5p/COX2 Axis to Inhibit Inflammation.清热解毒化瘀汤通过调节miR-26b-5p/COX2轴抑制炎症来缓解急性软组织损伤
Biosci Rep. 2020 Dec 3;40(12). doi: 10.1042/BSR20201981.
2
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.非甾体抗炎药在实际应用中导致急性心肌梗死的风险：个体患者数据的贝叶斯荟萃分析
BMJ. 2017 May 9;357:j1909. doi: 10.1136/bmj.j1909.
3
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity.NSAIDs 风云变幻的十年：分类、流行病学、疗效比较和毒性的最新概念更新。
Rheumatol Int. 2012 Jun;32(6):1491-502. doi: 10.1007/s00296-011-2263-6. Epub 2011 Dec 23.
4
Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis.口服环氧化酶-2 抑制剂与其他口服镇痛药治疗急性软组织损伤的系统评价和荟萃分析。
Clin Drug Investig. 2010;30(7):419-37. doi: 10.2165/11533350-000000000-00000.
5
6
Changes in rates of upper gastrointestinal hemorrhage after the introduction of cyclooxygenase-2 inhibitors in British Columbia and Ontario.在不列颠哥伦比亚省和安大略省引入环氧化酶-2抑制剂后上消化道出血发生率的变化。
CMAJ. 2006 Dec 5;175(12):1535-8. doi: 10.1503/cmaj.050192.
7
What influences seniors' choice of medications for osteoarthritis? Qualitative inquiry.什么影响老年人对骨关节炎药物的选择？定性调查。
Can Fam Physician. 2006 Mar;52(3):342-3.
8
Managing osteoarthritis. Medication use among seniors in the community.骨关节炎的管理。社区老年人的药物使用情况。
Can Fam Physician. 2004 Dec;50:1664-70.
9
Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635].鼓励医生合理开具非甾体抗炎治疗药物：一项随机对照试验的方案 [国际标准随机对照试验编号：ISRCTN43532635]
BMC Health Serv Res. 2004 Aug 24;4(1):21. doi: 10.1186/1472-6963-4-21.
10
Why don't we initiate more large simple randomized controlled trials?我们为什么不开展更多大型简单随机对照试验呢？
CMAJ. 2003 Nov 25;169(11):1170-1.
本文引用的文献
1
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.罗非昔布与萘普生对类风湿关节炎患者上消化道毒性的比较。VIGOR研究组。
N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103.
2
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.塞来昔布与非甾体抗炎药治疗骨关节炎和类风湿关节炎的胃肠道毒性：CLASS研究：一项随机对照试验。塞来昔布长期关节炎安全性研究。
JAMA. 2000 Sep 13;284(10):1247-55. doi: 10.1001/jama.284.10.1247.
Zotero 插件